Coller Capital
China secondaries: Willing sellers?
Few, if any, LPs are so desperate to divest China exposure that they will sell fund positions at any price. The main sticking point for secondary transactions is a disconnect on valuations
LPs eye secondaries to meet liquidity, rebalancing needs - Coller
Generating liquidity and rebalancing portfolios are the overwhelming priorities for LPs looking to sell in the secondaries market in the next two years, according to Coller Capital’s latest private equity barometer survey.
Coller closes first deal for debut renminbi fund
Coller Capital has completed the first deal from its debut renminbi-denominated secondaries fund, participating in a CNY 315m (USD 46m) GP-led transaction involving healthcare assets held by Chinese VC firm Legend Capital.
Coller launches $218m renminbi secondaries fund
Coller Capital has launched a renminbi secondaries fund with a target of CNY 1.5bn (USD 218m), confirming it has secured a first close of undisclosed size.
2023 preview: Private debt
Asia-based private debt managers hope to take advantage of renewed LP appetite for the asset class, while enjoying higher returns driven by rising interest rates and widening spreads
Overallocation-driven secondary sales more talk than action – Coller
More LPs are considering sales of private equity positions via the secondary market as they find themselves overallocated to the asset class following sharp adjustments in public markets valuations, but Coller Capital has yet to see this translate into...
Deal focus: Hahn & Co takes GP-led secondaries to new high
Hahn & Company has closed a USD 1.5bn single-asset continuation fund for Korea's Ssangyong C&E, giving it more time to complete the company's transition from cement maker to broader environmental services player
LPs warm up to crypto strategies – survey
Two in five LPs regard crypto-enabling businesses as a legitimate investment target, according to Coller Capital’s latest private equity barometer survey, underlining the sector’s emergence as a mainstream target for PE and VC.
China secondaries: Liquidity play
Under pressure to generate returns amid a challenging fundraising environment, Chinese GPs are beginning to revise pricing expectations to get traction with continuation funds
Coller secures $1.4b for global credit secondaries fund
Coller Capital has raised approximately USD 1.4bn for its debut global private credit secondaries fund, said to be the largest pool of capital dedicated to the strategy.
2022 preview: ESG
Keeping tabs on sustainability credentials at the portfolio and company level will become more data-driven and collaborative. Eventually, getting results will require greater sacrifices
Investors emphasize GP-LP alignment - AVCJ Forum
Eroding the alignment of interest between GP and LP – by tweaking the partnership structure, a manager overstretching to pursue multiple strategies, or conflicts emerging over secondaries – could harm returns at a time when valuations are already...
Q&A: Coller Capital’s Francois Aguerre
Francois Aguerre, head of origination at Coller Capital, on the march towards a $500 billion global secondaries market, the rise of GP-led transactions, and the implications of more permanent capital
CDC spinout seeks $500m for India secondaries fund
Stratford House Advisors, an India-focused secondaries investor established by two former executives from CDC Group, is looking to raise $500 million for a dedicated country fund.
Coller spins out credit fund interests from Ping An subsidiary
A Coller Capital-led consortium has acquired interests in four global credit funds – worth a combined $680 million – from China Ping An Insurance’s overseas investment platform.
LPs see no let-up in pace of new commitments - survey
More than half of LPs continue to establish new GP relationships at the same rate as before the pandemic, according to the latest installment of Coller Capital’s global private equity barometer survey.
Asia secondaries: Continuation conundrum
The rapid ascent of single-asset continuation vehicles in the US and Europe might be emulated in Asia, but investors are approaching the market with measured optimism
Legend closes China healthcare continuation fund
Legend Capital has spun out the healthcare assets from two of its China venture capital funds into a continuation vehicle supported by Hamilton Lane and Coller Capital. The $270 million deal includes capital for follow-on investments.
The crystal ball: Predictions for 2021
Industry professionals process the upheavals of 2020 to inform outlooks for a range of markets and investment themes. Realist bullishness abounds
Investor relations: Talk isn't cheap
The enforced adoption of virtual communications points to longer-term changes in investor relations, from annual general meetings to informal catch-ups. GPs must find ways to stand out
LPs anticipate PE portfolio restructuring - survey
A wave of portfolio restructuring is likely as LPs turn to the secondary market to reshape their private equity exposure, source new credit facilities or dispose of assets to remedy liquidity shortfalls, and review co-investment policies, Coller Capital’s...
ESG & secondaries: Finer filters
Rising sustainability standards pose unique challenges for investors that prefer buying into existing portfolios. Interestingly, increasingly complex deal structures are making it easier
GPs & climate change risk: Material matters
Climate change risk is becoming a broader debate within private equity, taking in the long-term impact of floods, droughts, and fires on portfolios. Most GPs have yet to turn thought into action